Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Eukaryotic Gene Expression
Facteur d'impact: 1.841 Facteur d'impact sur 5 ans: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimer: 1045-4403
ISSN En ligne: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2017019473
pages 99-112

Phytoestrogens and Related Food Components in the Prevention of Cancer

Muhammad Imran Qadir
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Bosan Road, Multan, Pakistan
Bushra Nawaz Cheema
Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan

RÉSUMÉ

Great progress has been made in the fight against disease in many different fields of medicine, especially in the field of natural medicine. Phytoestrogens and related compounds play a major role in the prevention and treatment of cancer. Chemoprevention, a narrative approach for controlling cancer, involves the use of specific natural products or synthetic chemical agents to overturn, repress, or prevent pre-malignancy before the development of invasive cancer. Several natural products confer protective effects against a wide range of cancers; examples include grains, nuts, cereals, spices, fruits, vegetables, beverages, medicinal plants, herbs, and their various phytochemical constituents including phenolics, flavonoids, carotenoids, and nitrogen-containing and organosulfur compounds. Phytoestrogens and related compounds act by different mechanisms that ultimately provide benefit with minimum or no side effects and protect and treat different types of cancer, including liver, lung, colon, breast, prostate, esophagus, oral, intestinal, and many other carcinomas.


Articles with similar content:

Cancer Chemotherapy With Lipid-Based Nanocarriers
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.27, 2010, issue 5
Na Zhang, Donghua Liu
Natural Products as Inhibitors of Epidermal Growth Factor Receptor
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 4
Thomas Efferth
Interactions between a Plasma-Activated Medium and Cancer Cells
Plasma Medicine, Vol.6, 2016, issue 1
Masaru Hori, Hiromasa Tanaka, Masaaki Mizuno, Fumitaka Kikkawa
Drug Delivery Systems for the Treatment of Restenosis
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.17, 2000, issue 3
Gershon Golomb, Michael Chorny, Ilia Fishbein
Copine 3 as a Novel Potential Drug Target for Non-Small-Cell Lung Carcinoma
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 2
Kunnathur Murugesan Sakthivel , Venugopal Vinod Prabhu